Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil + remazolam vs propofol or sufentanil for painless gastroscopy and colonoscopy
ChiCTR2200065013Phase 4Not yet recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam mesylate in None (3 arms), sponsored by Lishui People's Hospital. Primary endpoint: Incidence of intraoperative respiratory depression. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolam mesylate
Beyond the preview
Go deeper on ChiCTR2200065013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065013.